global-leukemia-therapeutics-market-industry
Published

November 2016

Global Leukemia Therapeutics Market Growth, Trends & Forecasts (2016-2021)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The Global market for Leukemia Therapeutics is expected to reach $11.73 billion by the end of 2021 growing at a CAGR of around 4.7% from 2016 to 2021. Leukemia is a form of cancer which occurs when there is an excess of abnormal white blood cells in the blood. Under normal conditions, the blood forming cells of the bone marrow produce leukocytes for defense against viruses and bacteria. If the leukocytes are damaged and if they remained untreated they get accumulated in the body. The untreated cells then invade other parts of the body like spleen, liver and central nervous system. The main reasons causing leukemia are smoking, ionizing radiation, prior chemotherapy and Down syndrome.

The symptoms of leukemia include fever, pain in bones, weight loss, shortness of breath, bleeding under the skin, etc. The treatment of leukemia involves radiation therapy, targeted therapy, chemotherapy and bone marrow transplant. The Global Leukemia Therapeutics Market is segmented on the basis of Types (Acute Leukemia, Chronic Leukemia, Acute Myelogenous Leukemia and Chronic Myelogenous Leukemia), Drugs (Tosedosat, Sapacitabine, GA101, Vosaroxin, Revlimid, Omapro, Dacogen, Marqibo, Bosutinib, Graspa and Vidaza) and Region (North America, Europe, Asia Pacific and Rest of the World).

Drivers

Rise in innovative techniques generating drugs, rise in the incidence of leukemia due to change in lifestyle and largest market with fretting needs are some of the major reasons driving the market growth.

Challenges

High cost of drugs and large number of entry-to-market barriers are some of the challenges faced by the market.

What the report offers:

  • Market Definition for the specified topic along with identification of key drivers and restraints for the market.
  • Market analysis for the Global Leukemia Therapeutics Market, with region specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
  • Identification and analysis of the Macro and Micro factors that affect the Global Leukemia Therapeutics Market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

 

 

RELATED REPORTS

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?